Metraipolis › archive › dc_f50eb8aac7ac

Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy — Europe PMC PMID:41633975

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41633975
DOI
10.1038/s41419-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-06T03:51:42.233Z
SHA-256 of the archived text
d94674a2d2cec8347b407a499d4c05dd734b8d92701edd32697ce78eca89f1fc
Stable URL of this page
https://metraipolis.com/documento/dc_f50eb8aac7ac

How to cite

Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy — Europe PMC PMID:41633975 — Europe PMC (en), https://europepmc.org/article/MED/41633975 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f50eb8aac7ac (Metraipolis archive dc_f50eb8aac7ac, sha256 d94674a2d2cec8347b407a499d4c05dd734b8d92701edd32697ce78eca89f1fc)
BibTeX
@misc{dcf50eb8aac7ac,
  title = {Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy — Europe PMC PMID:41633975},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41633975},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f50eb8aac7ac; sha256 d94674a2d2cec8347b407a499d4c05dd734b8d92701edd32697ce78eca89f1fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41633975. Agents can read the archived copy with the MCP tool read_document.